Point72 Asset Management’s Pfizer PFE Stock Holding History

Point72 Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.2M	Buy	861,000 +49,400	+6%	+$1.32M	0.03%	708
2025 Q4	$20.2M	Buy	811,600 +615,700	+314%	+$15.5M	0.02%	883
2025 Q3	$4.99M	Sell	195,900 -33,000	-14%	-$815K	0.01%	1066
2025 Q2	$5.55M	Buy	+228,900	New	+$5.34M	0.01%	934
2019 Q4	–	Sell	-316,200	Closed	-$10.8M	–	1182
2019 Q3	$10.8M	Hold	316,200	–	–	0.07%	346
2019 Q2	$13M	Buy	+316,200	New	+$12.6M	0.07%	337

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Point72 Asset Management's PFE Position: Q1 2026 in Review

Point72 Asset Management increased its Pfizer (PFE) stake by 32% in Q1 2026, buying an estimated $28.2M and bringing the position to 4,365,063 shares worth $123M. The position accounts for 0.16% of the portfolio, ranked #133.

Point72 Asset Management first reported a position in PFE in Q3 2014 and has held it in 12 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Point72 Asset Management held 4,365,063 shares of Pfizer worth $123M as of Q1 2026.
Point72 Asset Management bought 1,059,371 Pfizer shares in Q1 2026, an estimated $28.2M.
Pfizer made up 0.16% of Point72 Asset Management's portfolio in Q1 2026, its #133 holding.
Point72 Asset Management first reported a position in Pfizer in Q3 2014 and has held it in 12 quarters since.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.